5y9j
From Proteopedia
(Difference between revisions)
m (Protected "5y9j" [edit=sysop:move=sysop]) |
|||
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==BAFF in complex with belimumab== | |
| - | + | <StructureSection load='5y9j' size='340' side='right' caption='[[5y9j]], [[Resolution|resolution]] 2.05Å' scene=''> | |
| - | + | == Structural highlights == | |
| - | + | <table><tr><td colspan='2'>[[5y9j]] is a 3 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5Y9J OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5Y9J FirstGlance]. <br> | |
| - | + | </td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5y9j FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5y9j OCA], [http://pdbe.org/5y9j PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5y9j RCSB], [http://www.ebi.ac.uk/pdbsum/5y9j PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5y9j ProSAT]</span></td></tr> | |
| - | [[Category: | + | </table> |
| + | == Function == | ||
| + | [[http://www.uniprot.org/uniprot/TN13B_HUMAN TN13B_HUMAN]] Cytokine that binds to TNFRSF13B/TACI and TNFRSF17/BCMA. TNFSF13/APRIL binds to the same 2 receptors. Together, they form a 2 ligands -2 receptors pathway involved in the stimulation of B- and T-cell function and the regulation of humoral immunity. A third B-cell specific BAFF-receptor (BAFFR/BR3) promotes the survival of mature B-cells and the B-cell response.<ref>PMID:10973284</ref> Isoform 2 seems to inhibit isoform 1 secretion and bioactivity (By similarity).<ref>PMID:10973284</ref> | ||
| + | == References == | ||
| + | <references/> | ||
| + | __TOC__ | ||
| + | </StructureSection> | ||
| + | [[Category: Heo, Y S]] | ||
| + | [[Category: Shin, W]] | ||
| + | [[Category: Antibody]] | ||
| + | [[Category: Baff]] | ||
| + | [[Category: Belimumab]] | ||
| + | [[Category: Lupus]] | ||
| + | [[Category: Protein binding]] | ||
Revision as of 07:20, 22 February 2018
BAFF in complex with belimumab
| |||||||||||
Categories: Heo, Y S | Shin, W | Antibody | Baff | Belimumab | Lupus | Protein binding
